Delphi approach to select rare diseases for a European representative survey: The BURQOL-RD study

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autoren

  • BURQOL-RD Research Network

Externe Organisationen

  • Hospital de Gran Canaria Dr. Negrin
  • Red de Investigación en Servicios Sanitarios en Enfermedades Crónicas (REDISSEC)
  • Servicio canario de la Salud
  • Instituto de Salud Carlos III (ISCIII)
  • London School of Economics and Political Science
  • Istituto Superiore di Sanita
  • Istituto di Ricerche Farmacologiche Mario Negri
  • Bulgarian Association for Promotion of Education and Science (BAPES)
  • Health Economics and Health Technology Assessment Research Centre (HunHTA)
  • Federación Española de Enfermedades Raras (FEDER)
  • The Swedish Institute for Health Economics (IHE)
  • Université Paris-Est Créteil Val-de-Marne (UPEC)
  • Università Commerciale Luigi Bocconi
  • Centros de Investigacion Biomedica en Red - CIBER
  • BiomedRed
  • Universidad de Castilla-La Mancha
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)19-26
Seitenumfang8
FachzeitschriftHEALTH POLICY
Jahrgang108
Ausgabenummer1
Frühes Online-Datum2 Sept. 2012
PublikationsstatusVeröffentlicht - Nov. 2012

Abstract

Objectives: The BURQOL-RD project is intended to develop a disease based model capable of quantifying the socio-economic burden and health-related quality of life for patients with rare diseases (RDs) and their caregivers in Europe. We described the methodology used to select a set of 10 RDs to be approached in a pilot study. Methods: BURQOL-RD project includes 23 partners from 8 European countries: Spain, UK, France, Germany, Sweden, Italy, Hungary and Bulgaria. A two-round Delphi panels in combination with Carroll diagram was used to generate consensus in the selection of the 10 RDs among the project participants. Results: The two Delphi rounds yielded a prioritised list, to which the Carroll diagram was applied, taking into account three determinants: prevalence, availability of effective treatment and need for carer. The final set of RD to be studied was obtained: cystic fibrosis, Prader-Willi syndrome, haemophilia, duchenne muscular dystrophy, epidermolysis bullosa, fragile X syndrome, scleroderma, mucopolysaccharidosis, juvenile idiopathic arthritis and histiocytosis. Conclusions: This methodology permitted the generation of an equilibrated set of RDs for the pilot study of BURQOL-RD project. The model will be suitable for application in a wide range of RDs.

ASJC Scopus Sachgebiete

Ziele für nachhaltige Entwicklung

Zitieren

Delphi approach to select rare diseases for a European representative survey: The BURQOL-RD study. / BURQOL-RD Research Network.
in: HEALTH POLICY, Jahrgang 108, Nr. 1, 11.2012, S. 19-26.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

BURQOL-RD Research Network. Delphi approach to select rare diseases for a European representative survey: The BURQOL-RD study. HEALTH POLICY. 2012 Nov;108(1):19-26. Epub 2012 Sep 2. doi: 10.1016/j.healthpol.2012.08.001
BURQOL-RD Research Network. / Delphi approach to select rare diseases for a European representative survey : The BURQOL-RD study. in: HEALTH POLICY. 2012 ; Jahrgang 108, Nr. 1. S. 19-26.
Download
@article{ee08ea8b1f664eaabf9751c74eae5572,
title = "Delphi approach to select rare diseases for a European representative survey: The BURQOL-RD study",
abstract = "Objectives: The BURQOL-RD project is intended to develop a disease based model capable of quantifying the socio-economic burden and health-related quality of life for patients with rare diseases (RDs) and their caregivers in Europe. We described the methodology used to select a set of 10 RDs to be approached in a pilot study. Methods: BURQOL-RD project includes 23 partners from 8 European countries: Spain, UK, France, Germany, Sweden, Italy, Hungary and Bulgaria. A two-round Delphi panels in combination with Carroll diagram was used to generate consensus in the selection of the 10 RDs among the project participants. Results: The two Delphi rounds yielded a prioritised list, to which the Carroll diagram was applied, taking into account three determinants: prevalence, availability of effective treatment and need for carer. The final set of RD to be studied was obtained: cystic fibrosis, Prader-Willi syndrome, haemophilia, duchenne muscular dystrophy, epidermolysis bullosa, fragile X syndrome, scleroderma, mucopolysaccharidosis, juvenile idiopathic arthritis and histiocytosis. Conclusions: This methodology permitted the generation of an equilibrated set of RDs for the pilot study of BURQOL-RD project. The model will be suitable for application in a wide range of RDs.",
keywords = "Burden of illness, Delphi approach, Health-related quality of life, Rare diseases",
author = "{BURQOL-RD Research Network} and Renata Linertov{\'a} and Pedro Serrano-Aguilar and Manuel Posada-de-la-Paz and Manuel Hens-P{\'e}rez and Panos Kanavos and Domenica Taruscio and Arrigo Schieppati and Rumen Stefanov and M{\'a}rta P{\'e}ntek and Claudia Delgado and {Graf von der Schulenburg}, {Johann Matthias} and Ulf Persson and Karine Chevreul and Giovanni Fattore and Melany Worbes-Cerezo and Mark Sefton and Julio L{\'o}pez-Bastida",
year = "2012",
month = nov,
doi = "10.1016/j.healthpol.2012.08.001",
language = "English",
volume = "108",
pages = "19--26",
journal = "HEALTH POLICY",
issn = "0168-8510",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

Download

TY - JOUR

T1 - Delphi approach to select rare diseases for a European representative survey

T2 - The BURQOL-RD study

AU - BURQOL-RD Research Network

AU - Linertová, Renata

AU - Serrano-Aguilar, Pedro

AU - Posada-de-la-Paz, Manuel

AU - Hens-Pérez, Manuel

AU - Kanavos, Panos

AU - Taruscio, Domenica

AU - Schieppati, Arrigo

AU - Stefanov, Rumen

AU - Péntek, Márta

AU - Delgado, Claudia

AU - Graf von der Schulenburg, Johann Matthias

AU - Persson, Ulf

AU - Chevreul, Karine

AU - Fattore, Giovanni

AU - Worbes-Cerezo, Melany

AU - Sefton, Mark

AU - López-Bastida, Julio

PY - 2012/11

Y1 - 2012/11

N2 - Objectives: The BURQOL-RD project is intended to develop a disease based model capable of quantifying the socio-economic burden and health-related quality of life for patients with rare diseases (RDs) and their caregivers in Europe. We described the methodology used to select a set of 10 RDs to be approached in a pilot study. Methods: BURQOL-RD project includes 23 partners from 8 European countries: Spain, UK, France, Germany, Sweden, Italy, Hungary and Bulgaria. A two-round Delphi panels in combination with Carroll diagram was used to generate consensus in the selection of the 10 RDs among the project participants. Results: The two Delphi rounds yielded a prioritised list, to which the Carroll diagram was applied, taking into account three determinants: prevalence, availability of effective treatment and need for carer. The final set of RD to be studied was obtained: cystic fibrosis, Prader-Willi syndrome, haemophilia, duchenne muscular dystrophy, epidermolysis bullosa, fragile X syndrome, scleroderma, mucopolysaccharidosis, juvenile idiopathic arthritis and histiocytosis. Conclusions: This methodology permitted the generation of an equilibrated set of RDs for the pilot study of BURQOL-RD project. The model will be suitable for application in a wide range of RDs.

AB - Objectives: The BURQOL-RD project is intended to develop a disease based model capable of quantifying the socio-economic burden and health-related quality of life for patients with rare diseases (RDs) and their caregivers in Europe. We described the methodology used to select a set of 10 RDs to be approached in a pilot study. Methods: BURQOL-RD project includes 23 partners from 8 European countries: Spain, UK, France, Germany, Sweden, Italy, Hungary and Bulgaria. A two-round Delphi panels in combination with Carroll diagram was used to generate consensus in the selection of the 10 RDs among the project participants. Results: The two Delphi rounds yielded a prioritised list, to which the Carroll diagram was applied, taking into account three determinants: prevalence, availability of effective treatment and need for carer. The final set of RD to be studied was obtained: cystic fibrosis, Prader-Willi syndrome, haemophilia, duchenne muscular dystrophy, epidermolysis bullosa, fragile X syndrome, scleroderma, mucopolysaccharidosis, juvenile idiopathic arthritis and histiocytosis. Conclusions: This methodology permitted the generation of an equilibrated set of RDs for the pilot study of BURQOL-RD project. The model will be suitable for application in a wide range of RDs.

KW - Burden of illness

KW - Delphi approach

KW - Health-related quality of life

KW - Rare diseases

UR - http://www.scopus.com/inward/record.url?scp=84867336987&partnerID=8YFLogxK

U2 - 10.1016/j.healthpol.2012.08.001

DO - 10.1016/j.healthpol.2012.08.001

M3 - Article

C2 - 22947412

AN - SCOPUS:84867336987

VL - 108

SP - 19

EP - 26

JO - HEALTH POLICY

JF - HEALTH POLICY

SN - 0168-8510

IS - 1

ER -